SAN CARLOS, Calif. & LISBON, Portugal--March 7, 2024--CuraSen Therapeutics, Inc., a clinical-stage company developing small molecule therapies to treat neurodegenerative disease, announced that it will present additional positive Phase 2a...
Eric Linsley will lead a discussion on "Partnering and Licensing in Neurotech" at the 2012 Neurotech Investing & Partnering Conference on May 21-22 in Boston.
News | 02. 21. 2012
Eric Linsley will lead a discussion on "Partnering and Licensing in Neurotech" at the 2012 Neurotech Investing & Partnering Conference on May 21-22 in Boston.
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.